Tetramisole hydrochloride |
![]() Last updated: 16/09/2025 |
![]() |
(Not known by any other names) |
|
![]() |
|
A broad-spectrum anthelmintic used in veterinary medicine | |
---|---|---|
|
Used to treat many important helminth or worm infections including hookworm and ascariasis | |
|
Pigs; Cattle; Sheep; Goats |
Approval status |
|
Not approved | |
---|---|---|
|
Not approved |
Chemical structure |
|
Tetramisole hydrochloride exhibits stereoisomerism, specifically enantiomerism, due to the presence of a chiral centre in its imidazothiazole ring system. It exists as a racemic mixture of two enantiomers: the L-isomer (levamisole) and the D-isomer. The L-isomer, levamisole, is the pharmacologically active component responsible for the drug’s anthelmintic and immunomodulatory effects, while the D-isomer is largely inactive. | |
---|---|---|
|
C₁₁H₁₃ClN₂S | |
|
C1CSC2=NC(CN21)C3=CC=CC=C3.Cl | |
|
- | |
|
LAZPBGZRMVRFKY-UHFFFAOYSA-N | |
|
InChI=1S/C11H12N2S.ClH/c1-2-4-9(5-3-1)10-8-13-6-7-14-11(13)12-10;/h1-5,10H,6-8H2;1H | |
|
Yes |
|
![]() |
Common Name | Relationship | Link |
---|---|---|
tetramisole hydrochloride | - | ![]() |
tetramisole | Parent | ![]() |
General status |
|
Anthelmintic agent; Dewormer, Antiparasitic | |
---|---|---|
|
Imidazothiazole | |
|
- | |
|
- | |
|
Synthetic | |
|
An alkaline phosphatase inhibitor with antihelminthic and anticancer properties. It inhibits parasite growth by acting as an agonist to nicotinic acetylcholine receptors leading to paralysis. Anti-cancer mode of action is unknown | |
|
[Potassium channel Kir2.1 subunit, Agonist] | |
|
5086-74-8 | |
|
165-80-5; 4641-34-3 | |
|
225-799-5 | |
|
- | |
|
- | |
|
- | |
|
Antiparasitic products, insecticides & repellents: Anthelmintics | |
|
QP52AE01 | |
|
No | |
|
Allowed substance (Table 1: Bovine, Ovine, Porcine, Poultry) | |
|
240.75 | |
|
- | |
|
6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole;hydrochloride | |
|
- | |
|
- | |
|
- | |
|
- | |
|
- | |
|
Commercial |
|
|
|||
---|---|---|---|---|
|
Current | |||
|
1960s, first synthesised; 1970s, vet use introduced; 2013, not approved UK | |||
|
|
|||
|
|
|||
|
Supplied as soluble powders and concentrate solutions typically administered via drinking water or feed | |||
|
Tetramisole hydrochloride is synthesised through a multi-step chemical process beginning with the formation of the imidazothiazole ring system. One common route involves reacting 6-chloro-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole with benzene in the presence of a catalyst and organic solvents such as acetone or ethanol. This intermediate compound is then subjected to acidification using hydrochloric acid, which facilitates salt formation, yielding tetramisole hydrochloride. | |||
|
Published GHG data is not available for most pharmaceuticals. However, according to industry, global averages suggest producing 1 kg of a typical active pharmaceutical ingredient can range from 10 to 100 kg CO₂e for small molecule drugs and potentially up to 1000 kg CO₂e for complex biologicals such as vaccines, depending on the drug type, its formulation, complexity of synthesis, solvent recovery, and energy sources used. |
|
![]() |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
228 | Q3 Q = Miscellaneous data from online sources 3 = Unverified data of known source |
- | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
- | |||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
Substance may enter the environment via the faeces of treated animals or by leaching from spilt medicated feed. |
Degradation |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
As this parameter is not normally measured directly, a surrogate measure is used: ‘Photochemical oxidative DT₅₀’. Where data is available, this can be found in the Fate Indices section below. | ||||||||||
|
- |
Soil adsorption and mobility |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | ||||||||||
|
- | ||||||||||
|
- |
Fate indices |
|
|
|
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||||||||||||||||||||
|
|
- | - | - | |||||||||||||||||||||||||
|
- | - |
Known metabolites |
None
|
![]() |
Terrestrial ecotoxicology |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | |||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
- | |||||||||||
|
- | - | - | ||||||||
- | |||||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - |
Aquatic ecotoxicology |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - |
|
- | - | - | |||
|
- | - | - |
|
![]() |
General |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
High (class III) | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | |||||||||
|
- | ||||||||||
|
Eliminated via hepatic metabolism, followed by renal excretion mainly via the urine, with a smaller portion eliminated through the faeces. | Q3 Q = Miscellaneous data from online sources 3 = Unverified data of known source |
- |
Health issues |
|
|
||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Possible immune system and blood toxicant May cause stomatitis, nausea, vomiting and adbominal pain |
Handling issues |
|
|
|||
---|---|---|---|---|
|
IMDG Transport Hazard Class 6.1 | |||
|
- | |||
|
Not listed (Not listed) | |||
|
UN2811 | |||
|
Packaging Group III (minor danger) | |||
|
- |
|
![]() |
|
|
||
---|---|---|---|
|
tetramisole hydrochloride | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- |
Record last updated: | 16/09/2025 |
Contact: | aeru@herts.ac.uk |
Please cite as: | Lewis, K.A., Tzilivakis, J., Warner, D. and Green, A. (2016) An international database for pesticide risk assessments and management. Human and Ecological Risk Assessment: An International Journal, 22(4), 1050-1064. DOI: 10.1080/10807039.2015.1133242 |